The government says serious reactions to a dose of the vaccine are "extremely rare."
The Ontario government has just reported its first case of "rare" AstraZeneca-linked blood clotting.
In a press release, it was confirmed that a man in his 60s who received his first dose of the AstraZeneca vaccine is now recovering at home after experiencing a case of vaccine-induced immune thrombotic thrombocytopenia (VITT).
The government is reminding residents that serious reactions to a dose of the vaccine are "extremely rare."
This reported case of blood clotting is the fourth out of over 1.1 million AstraZeneca vaccine doses that have been administered across Canada.
"All COVID-19 vaccines available in the province have been determined to be safe and effective by Health Canada, and have been shown to prevent serious illness, hospitalization and death," reads the release.
Health Canada has a robust website with all the latest information on the vaccines and can answer any questions you may have. Click here for more information.